VEGFA Isoforms as Pro-Angiogenic Therapeutics for Cerebrovascular Diseases

VEGFA Isoforms as Pro-Angiogenic Therapeutics for Cerebrovascular Diseases

Therapeutic angiogenesis has long been considered a viable treatment for vasculature disruptions, including cerebral vasculature diseases. One widely-discussed treatment method to increase angiogenesis is vascular endothelial growth factor (VEGF) A. In animal models, treatment with VEGFA proved bene...

Full description

Bibliographic Details
Main Authors:	Amanda Louise White, Gregory Jaye Bix
Format:	Article
Language:	English
Published:	MDPI AG 2023-04-01
Series:	Biomolecules
Subjects:	VEGFA isoforms cerebral vasculature angiogenic therapy
Online Access:	https://www.mdpi.com/2218-273X/13/4/702

Similar Items

Shift in VEGFA isoform balance towards more angiogenic variants is associated with tumor stage and differentiation of human hepatocellular carcinoma
by: Mikhail S. Chesnokov, et al.
Published: (2018-06-01)

The inhibition of protein translation promotes tumor angiogenic switch
by: Hui Luo, et al.
Published: (2022-06-01)

Resistance to Anti-angiogenic Therapies: A Mechanism Depending on the Time of Exposure to the Drugs
by: Christopher Montemagno, et al.
Published: (2020-07-01)

VEGFA Status as a Predictive Marker of Therapy Outcome in Metastatic Gastric Cancer Patients Following Ramucirumab-Based Treatment
by: Annalisa Schirizzi, et al.
Published: (2023-10-01)

Differential action of pro-angiogenic and anti-angiogenic components of Danhong injection in ischemic vascular disease or tumor models
by: Shuang He, et al.
Published: (2022-01-01)

Diagnostic and Therapeutic Values of Angiogenic Factors in Endometrial Cancer
by: Luka Roškar, et al.
Published: (2021-12-01)

Pro-angiogenic therapeutics for preeclampsia
by: Adrian C. Eddy, et al.
Published: (2018-08-01)

Interaction of epitopic missense variants of VEGFA with therapeutic monoclonal antibodies
by: Md Tamzid Hossain Tanim, et al.
Published: (2023-08-01)

Progress on angiogenic and antiangiogenic agents in the tumor microenvironment
by: Jian Xu, et al.
Published: (2024-11-01)

A therapy inactivating the tumor angiogenic factors
by: Cristian Morales-Rodrigo
Published: (2012-11-01)

Integration of single-cell and spatial transcriptomics reveals fibroblast subtypes in hepatocellular carcinoma: spatial distribution, differentiation trajectories, and therapeutic potential
by: Yue Liu, et al.
Published: (2025-02-01)

Homeostatic Regulation of Pro-Angiogenic and Anti-Angiogenic Proteins via Hedgehog, Notch Grid, and Ephrin Signaling in Tibial Dyschondroplasia
by: Shah Nawaz, et al.
Published: (2023-12-01)

Fibrotic Changes and Endothelial-to-Mesenchymal Transition Promoted by VEGFR2 Antagonism Alter the Therapeutic Effects of VEGFA Pathway Blockage in a Mouse Model of Choroidal Neovascularization
by: Franco Aparecido Rossato, et al.
Published: (2020-09-01)

Autophagy inhibition potentiates the anti-angiogenic property of multikinase inhibitor anlotinib through JAK2/STAT3/VEGFA signaling in non-small cell lung cancer cells
by: Lijun Liang, et al.
Published: (2019-02-01)

THE ROLE OF VEGFA GENE POLYMORPHISM IN DIABETIC FOOT SYNDROME DEVELOPMENT
by: A. V. Rusanov, et al.
Published: (2019-06-01)

VEGFA may be a potential marker of myopic choroidal thickness and vascular density changes
by: Ting Wan, et al.
Published: (2024-09-01)

Genome Editing VEGFA Prevents Corneal Neovascularization In Vivo
by: Zhenhai Zeng, et al.
Published: (2024-07-01)

Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies
by: Changyu Yao, et al.
Published: (2023-01-01)

Preclinical Efficacy of Pro- and Anti-Angiogenic Peptide Hydrogels to Treat Age-Related Macular Degeneration
by: Amanda Acevedo-Jake, et al.
Published: (2021-11-01)

Anti-angiogenic therapeutic strategies in hereditary hemorrhagic telangiectasia
by: Daniela S. Ardelean, et al.
Published: (2015-02-01)

Adjustable delivery of pro-angiogenic FGF-2 by alginate:collagen microspheres
by: Zaheer Ali, et al.
Published: (2018-03-01)

miR-203 Suppresses Tumor Growth and Angiogenesis by Targeting VEGFA in Cervical Cancer
by: Xiangyu Zhu, et al.
Published: (2013-07-01)

Identification of novel somatic fusions of ERG‐VEGFA, TMPRSS2‐ERG, and VEGFA‐TMPRSS2 in prostate cancer treated with anlotinib and androgen deprivation therapy: A case report
by: Qiuli Liu, et al.
Published: (2022-06-01)

Sensitivity analysis unveils the interplay of drug-sensitive and drug-resistant Glioma cells: Implications of chemotherapy and anti-angiogenic therapy
by: Latifah Hanum, et al.
Published: (2024-01-01)

VEGFA, MYC, and JUN are abnormally elevated in the synovial tissue of patients with advanced osteoarthritis
by: Genxiang Rong, et al.
Published: (2025-01-01)

CircRNA-miRNA-VEGFA: an important pathway to regulate cancer pathogenesis
by: Lei Zhang, et al.
Published: (2023-05-01)

Asiaticoside inhibits breast cancer progression and tumor angiogenesis via YAP1/VEGFA signal pathway
by: Mengmeng Guo, et al.
Published: (2024-09-01)

The VEGFA gene and anterior cruciate ligament rupture risk in the Caucasian population
by: Ewelina Lulińska-Kuklik, et al.
Published: (2018-10-01)

tRNA synthetase counteracts c-Myc to develop functional vasculature
by: Yi Shi, et al.
Published: (2014-06-01)

Hypoxia-autophagy axis induces VEGFA by peritoneal mesothelial cells to promote gastric cancer peritoneal metastasis through an integrin α5-fibronectin pathway
by: Xiaoxun Wang, et al.
Published: (2020-10-01)

VEGFA contributes to tumor property of glioblastoma cells by promoting differentiation of myeloid-derived suppressor cells
by: Yanlong Tian, et al.
Published: (2024-08-01)

Association of <i>VEGFA</i> gene rs2010963 polymorphism with cervical cancer and its progression
by: Artem V. Rogalev, et al.
Published: (2023-12-01)

Alternative splicing of VEGFA is regulated by RBM10 in endometrial cancer
by: Xiao‐Qing Dou, et al.
Published: (2020-01-01)

Significance of anti-angiogenic therapy in head and neck cancer—Heterogeneity of tumor endothelium
by: Kyoko Hida, et al.
Published: (2010-02-01)

Dual VEGFA/BRAF targeting boosts PD‐1 blockade in melanoma through GM‐CSF‐mediated infiltration of M1 macrophages
by: Valentina Comunanza, et al.
Published: (2023-08-01)

Vascular endothelial growth factor (VEGFA) gene variation in polycystic ovary syndrome in a Tunisian women population
by: Assila Ben Salem, et al.
Published: (2016-10-01)

VEGFA, VEGFR1, VEGFR2 serum and cerebrospinal fluid concentration in patients with acute leukemia
by: E. I. Zakharko, et al.
Published: (2024-04-01)

Synergistic Anti-Angiogenic Effects Using Peptide-Based Combinatorial Delivery of siRNAs Targeting VEGFA, VEGFR1, and Endoglin Genes
by: Anna A. Egorova, et al.
Published: (2019-06-01)

TJP1 promotes vascular mimicry in bladder cancer by facilitating VEGFA expression and transcriptional activity through TWIST1
by: Zhao-Xia Dong, et al.
Published: (2023-06-01)

Effect of sunitinib against Echinococcus multilocularis through inhibition of VEGFA-induced angiogenesis
by: Huijiao Jiang, et al.
Published: (2023-11-01)